The National Institutes of Health (NIH) has launched an initiative to tackle the opioid crisis, focusing on developing better overdose reversal and prevention interventions, finding new medications and technologies to treat addiction, and creating safe strategies for managing chronic pain.
A new metric called the Relative Citation Ratio (RCR) allows researchers to evaluate article influence regardless of publication or field. RCR is benchmarked to a peer comparison group, providing a more accurate measure of an article's impact.
A recent NIH survey found 79% of respondents willing to participate in the Precision Medicine Initiative Cohort Program, a nationwide research effort aimed at personalizing healthcare based on individual differences. The program, which aims to engage 1 million participants, shows promise for improving disease prevention and treatment.
A comprehensive study of the genetics of type 2 diabetes has unveiled significant details about the disease's underlying mechanisms. The research identified common genetic variants that contribute to an individual's risk of developing the disease, as well as genes and proteins directly involved in its development.
The National Institutes of Health is launching a landmark longitudinal research effort, the Precision Medicine Cohort Program, with $55 million in funding. The program aims to engage 1 million or more U.S. participants to improve disease prevention and treatment based on individual differences in lifestyle, environment, and genetics.
The Open Science Prize has announced six team finalists to develop prototypes addressing big data access and usage challenges. The teams will receive $80,000 each and compete for the grand prize of $230,000.
The National Institutes of Health has awarded $10.1 million in supplemental funding to bolster the research of 82 grantees exploring sex effects in preclinical and clinical studies. This investment encourages researchers to consider sex as a fundamental variable, leading to greater awareness of the need to study both sexes.
The NIH has issued a final policy on genomic data sharing to promote the acceleration of biomedical research. The policy, which applies to all NIH-funded large-scale human and non-human projects, requires researchers to obtain informed consent from study participants for future use of their de-identified data.
The I-Corps at NIH pilot program aims to train business-minded biotech researchers to evaluate their scientific discoveries for commercial potential. The program will provide tools and resources to prospective entrepreneurs, including real-time interactions with potential customers and supplemental funding.
The NIH is introducing new policies to ensure that sex and gender are considered fundamental variables in all preclinical biomedical research funded by the agency. This move aims to address the significant gap in current research practices, which often neglect women's health and biological differences.
The National Institutes of Health is providing funding for innovative approaches to address workforce challenges in the biomedical research sector. The program aims to broaden trainees' exposure to multiple career options, enabling them to make meaningful contributions outside traditional academic research.
The FDA and NIH have created the first-of-kind Tobacco Centers of Regulatory Science (TCORS) program, which aims to generate research to inform tobacco product regulation and protect public health. The program will support research in seven core areas, including diversity of tobacco products, reducing addiction, and communications.
The NIH has reached an agreement with the Lacks family to allow controlled access to the whole genome data of HeLa cells, a valuable reference tool for researchers. The policy respects the family's wishes while enabling scientific progress and includes public acknowledgement of their contribution.
The US government has released two new documents to guide researchers in carrying out dual use research of concern. The new framework outlines a robust review process that takes into account scientific benefits, biosafety risks, and risk mitigation measures.
A new medical college admission test (MCAT) is proposed to prioritize knowledge of behavioral and social sciences. The authors argue that this shift will help practicing physicians address modifiable behaviors contributing to premature deaths in the US.
The NIH has launched an online resource called e-Source, which offers a range of interactive chapters, discussion forums, and references to help researchers apply behavioral and social science methods to public health activities. The resource is designed to provide a foundation for collaborations between biological and social scientists.
The NIH Director's Early Independence Awards (EIA) program allows exceptional junior investigators to bypass traditional post-doc training and establish independent research careers immediately. The first recipients, 10 outstanding young scientists, will receive $19.3 million in funding over five years.
A recent NIH-commissioned study found that black applicants were 10 percentage points less likely than white applicants to receive research project grants after controlling for factors such as education and affiliation. The study highlights the need for action to address racial disparities in the biomedical workforce.
The NIH Director's Transformative Research Projects (T-R01) award program provides funding for exceptionally innovative research ideas that have the potential for extraordinary impact. The program allows investigators to sidestep conventional stumbling blocks and propose daring ideas.
The NIH Common Fund has announced seven new scientific initiatives to tackle the toughest health problems facing the nation and the world. The programs focus on emerging science and technology advances in areas such as stem cells, protein capture, and global health.
The NIH is awarding grants to strengthen S.T.E.M. education nationwide, targeting young people in biomedical careers and improving science literacy in adults and children. The $18.3 million funding supports research to develop practical interventions for tomorrow's classrooms and addresses issues of equity in S.T.E.M. competencies.
The National Institutes of Health (NIH) has awarded $348 million in funding to encourage high-risk research and innovation. The funding is granted through three innovative research programs: the NIH Director's Transformative R01, Pioneer Awards, and New Innovator Awards.
The NIH Roadmap Epigenomics Program aims to understand how epigenetic processes control genes and affect health and disease. The program will provide reference data for the entire scientific community to study epigenetic regulation.
The NIH is launching a new initiative in epigenomics, a field that studies how genes are regulated, to better understand the role of environment in health and disease. The program aims to coordinate reference epigenome maps, evaluate epigenetic mechanisms, and develop new technologies for analysis.
The NIH is awarding $105 million to 41 innovative investigators through the Pioneer and New Innovator Awards. These grants will support groundbreaking research in various fields, including neuroscience, physics, and biology.
The NIH Roadmap for Medical Research is launching nine interdisciplinary research consortia to foster collaboration across multiple disciplines, addressing resistant health challenges. The program aims to transform academic research culture and provide a stimulus for academic research change.
The NIH State-of-the-Science panel recommends a broader use of cognitive and behavioral therapies to treat chronic insomnia, which has limited proven options. Research suggests that these methods can be effective in treating insomnia when combined with relaxation training.
A state-of-the-science panel urges caution in treating menopausal symptoms with hormones due to risks and limited evidence. Non-hormonal treatment approaches are recommended for further research.
The NIH Pioneer Award program aims to support groundbreaking biomedical research through individual scientist awards, promoting diversity in the field. Eligible scientists can submit self-nominations until April 1, 2005, with funding up to $500,000 for five years.
The NIH has suspended the use of celecoxib, a COX-2 inhibitor, in its large-scale cancer prevention trial after finding a two-fold increased risk of cardiovascular toxicities. The decision was made following a September 2004 report that highlighted concerns over the safety of rofecoxib, another COX-2 inhibitor.
The NIH panel's statement highlights the need for enhanced communication among patients, families, and providers, as well as recruitment of under-represented populations in end-of-life research. The panel also recommends creating networks of researchers and patient cohorts to facilitate coordinated studies.
The NIH has awarded $68 million to 1,407 new student loan repayment contracts in Fiscal Year 2004. These programs provide up to $35,000 of qualified educational debt repayment for health professionals pursuing careers in clinical, pediatric, contraception and infertility, or health disparities research.
The panel found that traditional 'get tough' approaches exacerbate problems, while positive intervention programs like Functional Family Therapy and Multisystemic Therapy show promise in reducing arrests and out-of-home placements. These effective programs focus on developing social competency skills and family involvement.
The NIH consensus panel confirms the effectiveness of total knee replacement surgery, highlighting the importance of surgeon volume and proper prosthesis alignment to minimize long-term complications. Computer navigation technology may eventually reduce malalignment risks but is currently unproven and costly.
The 2002 Annual Bibliography of Significant Advances in Dietary Supplement Research highlights recent studies on the role of antioxidants, vitamins, and minerals in managing various health conditions. The publication features a list of top 25 articles selected from over 350 original research papers.
The new Center for Dietary Supplement Research at the University of Iowa will investigate the health benefits and safety of Echinacea and St. John's wort. This research aims to advance knowledge on botanicals, including their effectiveness, safety, and biological action.
A panel of experts calls for improved symptom management for cancer patients, citing undertreatment of pain, depression, and fatigue. The panel emphasizes the need for evidence-based treatments and routine assessment tools to ensure optimal symptom control.
The consensus panel recommends expanding hepatitis C treatment to include patients who use injected drugs, suffer from co-morbid conditions, or are coinfected with HIV. Reliable HCV cultures and research networks are also prioritized to advance understanding of the disease and develop new treatments.
The NIH panel recommends surgically removing tumors over 6cm in size, while those between 4-6cm may be removed based on hormone production. Minimally invasive surgery is suitable for smaller, non-cancerous tumors.
The NIH/Office of the Director's panel endorses ERCP for diagnosing suspected ampullary cancers and treating conditions like symptomatic gallstone disease, but emphasizes caution due to potential complications such as pancreatitis.
A study found that certain genetic variants next to the human obesity (OB) gene are associated with obesity in young women, as well as depression and anxiety. The results suggest a direct link between the OB gene variants and depression, rather than just secondary effects.